Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assaying for I kappa B kinase activity.

× No keyword cloud information.

13 in total

1. NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha.

Authors: Dawn R Clifton; Elena Rydkina; Robert S Freeman; Sanjeev K Sahni
Journal: Infect Immun Date: 2005-01 Impact factor: 3.441

2. Biomechanical signals suppress TAK1 activation to inhibit NF-kappaB transcriptional activation in fibrochondrocytes.

Authors: Shashi Madhavan; Mirela Anghelina; Danen Sjostrom; Anar Dossumbekova; Denis C Guttridge; Sudha Agarwal
Journal: J Immunol Date: 2007-11-01 Impact factor: 5.422

3. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.

Authors: Aicha Saadane; Sophia Masters; Joseph DiDonato; Jingfeng Li; Melvin Berger
Journal: Am J Respir Cell Mol Biol Date: 2007-02-01 Impact factor: 6.914

4. Effect of inositol hexakisphosphate kinase 2 on transforming growth factor beta-activated kinase 1 and NF-kappaB activation.

Authors: Bei H Morrison; Joseph A Bauer; Joseph A Lupica; Zhuo Tang; Heidi Schmidt; Joseph A DiDonato; Daniel J Lindner
Journal: J Biol Chem Date: 2007-03-22 Impact factor: 5.157

5. RelA/p65 regulation of IkappaBbeta.

Authors: Erin Hertlein; Jingxin Wang; Katherine J Ladner; Nadine Bakkar; Denis C Guttridge
Journal: Mol Cell Biol Date: 2005-06 Impact factor: 4.272

6. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.

Authors: L Andresen; V L Jørgensen; A Perner; A Hansen; J Eugen-Olsen; J Rask-Madsen
Journal: Gut Date: 2005-04 Impact factor: 23.059

7. Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL.

Authors: Mamta Chawla-Sarkar; Joseph A Bauer; Joseph A Lupica; Bei H Morrison; Zhuo Tang; Rhonda K Oates; Alex Almasan; Joseph A DiDonato; Ernest C Borden; Daniel J Lindner
Journal: J Biol Chem Date: 2003-07-24 Impact factor: 5.157

8. Biomechanical signals inhibit IKK activity to attenuate NF-kappaB transcription activity in inflamed chondrocytes.

Authors: Anar Dossumbekova; Mirela Anghelina; Shashi Madhavan; Lingli He; Ning Quan; Thomas Knobloch; Sudha Agarwal
Journal: Arthritis Rheum Date: 2007-10

9. MyoD-dependent regulation of NF-κB activity couples cell-cycle withdrawal to myogenic differentiation.

Authors: Maura H Parker; Julia von Maltzahn; Nadine Bakkar; Ban Al-Joubori; Jeff Ishibashi; Denis Guttridge; Michael A Rudnicki
Journal: Skelet Muscle Date: 2012-05-19 Impact factor: 4.912

10. Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model.

Authors: Jianfeng Liu; Xin Gu; Delira Robbins; Guohong Li; Runhua Shi; Joe M McCord; Yunfeng Zhao
Journal: PLoS One Date: 2009-04-22 Impact factor: 3.240